Page last updated: 2024-10-27

6-(3,5-dimethylbenzyl)-1-(ethoxymethyl)-5-isopropyluracil and HIV Coinfection

6-(3,5-dimethylbenzyl)-1-(ethoxymethyl)-5-isopropyluracil has been researched along with HIV Coinfection in 1 studies

6-(3,5-dimethylbenzyl)-1-(ethoxymethyl)-5-isopropyluracil: an anti-HIV agent; structure in first source
6-(3,5-dimethylbenzyl)-1-(ethoxymethyl)-5-isopropyluracil : A pyrimidone that is uracil which is substituted at positions 1, 5, and 6 by ethoxymethyl, isopropyl, and 3,5-dimethylbenzyl groups, respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanaka, H1
Takashima, H1
Ubasawa, M1
Sekiya, K1
Inouye, N1
Baba, M1
Shigeta, S1
Walker, RT1
De Clercq, E1
Miyasaka, T1

Other Studies

1 other study available for 6-(3,5-dimethylbenzyl)-1-(ethoxymethyl)-5-isopropyluracil and HIV Coinfection

ArticleYear
Synthesis and antiviral activity of 6-benzyl analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents.
    Journal of medicinal chemistry, 1995, Jul-21, Volume: 38, Issue:15

    Topics: Animals; Antiviral Agents; Benzyl Compounds; HIV Infections; HIV-1; Humans; Lymphocytes; Mice; Micro

1995